Published by Coherent Market Insights
Posted on September 27, 2021
4 min readLast updated: February 2, 2026
The smoking cessation market is expanding due to health benefits and new products like NRT and e-cigarettes. Adolescent smoking remains a concern.
“The Smoking Cessation and Nicotine De-addiction Products Market 2021 – 2027 report covers the important factors driving the growth of the market, untapped opportunities for manufacturers, trends and developments shaping the dynamics of the market and other insights across various key segments.”
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/134
Smoking cessation is tremendously beneficial at virtually all ages, improves overall health, reduces healthcare costs and improves quality of life, which in turn aids in growth of the smoking cessation and nicotine de-addiction products market. However, well-designed smoking cessation research needs to be done, especially with adolescent smokers. Adolescent smokers are a rapidly growing population. As a population, they comprise a significant number of people, but their health risks and associated costs are not well studied. Understanding and reducing the burden of smoking on these young people can be effective in the effort to reduce the tobacco industry’s enormous revenue.
It is estimated that approximately three million teenagers in the United States smoke cigarettes. This estimate does not include many adolescents in other parts of the world who are affected by smoking prevalence. According to the 2018 National Survey on Drug Use and Health, in the U.S., around 164.8 million people aged 12 or older in the U.S. were past month substance users that included tobacco, alcohol, or illicit drugs. Such high number of substance users is expected to aid in growth of the smoking cessation and nicotine de-addiction products market.
Smokers have higher incidences of many serious illnesses, some of which are heart diseases and cancers. As cigarette demand increases in countries outside of the United States and Canada, smoking prevalence rises along with rates of heart disease and cancers. It is estimated that the eastern part of Canada (where smoking prevalence has been traditionally lowest) accounts for one fourth of all heart disease deaths in the world. Such incidence is expected to aid in growth of smoking cessation and nicotine de-addiction products market in North America.
Several studies have revealed that there may be a strong connection between nicotine use and depression in patients diagnosed with depression. Specifically, the study found that nicotine replacement therapy (NRT) and e-cigarettes were as effective at treating depression as Zyban, an anti-depressant medication. Thus, increasing demand for NRT and e-cigarettes is also expected to aid in growth of the smoking cessation and nicotine de-addiction products market.
Smoking cessation specialists are touting the benefits of NRT and e-cigarettes, but they acknowledge that there is still a long way to go towards the ultimate goals of a smoke-free world. The best solution to stop smoking is still a drug therapy, one that works over time, as opposed to instantly treating symptoms. The Canadian government and health organizations have begun examining the transdermal patches as a possible smoking cessation solution. These transdermal patches are designed to release a slowly increasing amount of nicotine into the body via the skin’s pores. Such initiatives aid in growth of the smoking cessation and nicotine de-addiction products market.
Top Key Players Include In Smoking Cessation and Nicotine De-addiction Products Market: Pfizer, Inc., GlaxoSmithKline Plc., Johnson & Johnson Limited, Cipla Limited, Perrigo Company Plc, Dr. Reddy’s Laboratories Limited, Imperial Brands Plc., NJOY, Inc., British American Tobacco P.L.C, and Japan Tobacco Inc.
The Smoking Cessation and Nicotine De-addiction Products Market is displayed in 13 Chapters:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities
Chapter 2: Market Competition by Manufacturers
Chapter 3: Production by Regions
Chapter 4: Consumption by Regions
Chapter 5: Production, By Types, Revenue and Market share by Types
Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications
Chapter 7: Complete profiling and analysis of Manufacturers
Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Market Forecast
Chapter 13: Smoking Cessation and Nicotine De-addiction Products Research Findings and Conclusion, Appendix, methodology and data source
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/134
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
Visit Our Blog For More Such Reports: https://www.coherentmarketinsights.com/blog
The post Smoking Cessation and Nicotine De-addiction Products Market 2021: Future Demand, Market Analysis and Outlook to 2027 appeared first on Gatorledger.
The article discusses the growth and trends in the smoking cessation and nicotine de-addiction products market from 2021 to 2027.
Health benefits of smoking cessation, new product developments, and rising adolescent smoking rates are key drivers.
Major players include Pfizer, GlaxoSmithKline, Johnson & Johnson, and others.
Explore more articles in the Research Reports category
